Product Details
| Product Name:
KL1333 |
CAS No.:
1800405-30-4 |
| Purity:
99.27% |
Supply Ability:
10g |
| Release date:
2024/11/11 |
Product Introduction
Bioactivity
| 名称 | KL1333 |
| 描述 | KL1333 (NQO1 activator 1) enhances energy metabolism and mitochondrial dysfunction in MELAS fibroblasts. Elevated NAD+ levels trigger the activation of SIRT1 and AMPK, and subsequently activates PGC-1α. NQO1 activator 1 is an orally available NAD+ modulator. It reacts with NAD(P)H: NQO1 as a substrate, resulting in increases in intracellular NAD+ levels via NADH oxidation. |
| 存储条件 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
| 溶解度 | DMSO : 245 mg/mL (1019.73 mM), Sonication is recommended.
|
| 关键字 | Mitochondrial Metabolism | Inhibitor | KL1333 | KL-1333 | inhibit | KL 1333 |
| 相关产品 | Imeglimin hydrochloride | Rotenone | Metronidazole | Resveratrol | Pasiniazid | Boscalid | α-Lipoic Acid | NAD+ | Lipoic acid | Apocynin | D-Histidine | Nerol |
| 相关库 | 铜死亡化合物库 | 经典已知活性库 | 药物功能重定位化合物库 | 线粒体靶向库 | 代谢化合物库 | 口服活性化合物库 | 抗衰老化合物库 | 临床期小分子药物库 | 已知活性化合物库 |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
-
-
CAS:362003-83-6
$54.00 / 5mg
-
CAS:219311-44-1
$53.00 / 1mg
Recommended supplier
| Product name |
Price |
|
Suppliers |
Update time |
|
|
$/ |
|
Anhui Ruihan Technology Co., Ltd
|
2023-08-21 |
United States